Deciphering posttranslational codes of the dioxin receptor
Deciphering posttranslational codes of the dioxin receptor
批准号:
nhmrc : 453687
负责人:
Prof Jeffrey Gorman
金额:
$36.01万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31
中文摘要
二恶英受体(DR)是一种蛋白质,通过结合外源物质(即在食物来源和一般环境中发现的外来或抗营养化学物质)来保护人体细胞。当这些化学物质与DR结合时,DR就变成了一种活跃的基因调节蛋白,开启了参与分解和排泄外源性药物的基因。最近已经发现DR具有与外源性分解无关的其他重要功能。这包括胚胎肝脏的血管发育和发情周期中激素的产生。这些观察结果表明,激活DR的自然生理机制也存在,为其提供了执行这些先天功能的单独代码。许多人造化学物质,如二恶英和多氯联苯,特别善于激活dr。然而,它们具有氯化的化学结构,不能被保护系统分解。这会产生一系列严重的毒性反应。已经确定,毒性是由DR的持续过度激活引起的,但这种过度激活如何诱导毒性结果尚不清楚。由于DR在早期发育和雌激素产生中起作用,本项目将研究DR如何被激活以执行这些功能。我们最初的实验表明,DR可以被正常的细胞信号系统激活,从而诱导蛋白质的不同修饰(不同的代码)。我们正在将这种修改代码与能够被分解的外源性药物和不易被分解的二恶英引起的修改代码进行比较。我们假设二恶英会提供过多的激活修饰代码,导致在发育和外源分解途径中使用的基因无法控制的调节。我们将探讨这种基因调控控制的严重损失是二恶英中毒的多种毒性的基础。
英文摘要
The dioxin receptor (DR) is a protein which protects human cells by binding xenobiotics, ie foreign or anti-nutritional chemicals found in food sources and the general environment. When these chemicals bind the DR, it becomes an active gene regulatory protein, turning on genes that are involved in breakdown and excretion of the xenobiotics. Recently it has been found that the DR performs other important functions which are unrelated to xenobiotic breakdown. These include blood vessel development in the embryonic liver and hormone production during the estrous cycle. These observations imply that natural physiological mechanisms also exist for activating the DR, providing it with a separate code to perform these innate functions. A number of man-made chemicals, such as dioxins and PCBs, are especially good at activating the DR. However, they have chlorinated chemical structures, which are not broken down by the protective system. This creates a wide range of severe toxic responses. It has been established that toxicities result from persistent hyperactivation of the DR, but how this hyperactivation induces the toxic outcomes is not known. As the DR has roles in early development and estrogen production, this project will investigate how the DR becomes activated to perform these functions. Our initial experiments have shown that the DR can be activated by normal cell signalling systems, which induce distinct modifications (a distinct code) to the protein. We are comparing this code of modifications to those induced by xenobiotics which are able to be broken down, and dioxins which are resistant to breakdown. We hypothesise that dioxins will give an excessive code of activating modifications, resulting in uncontrolled regulation of genes used in both the developmental and xenobiotic breakdown pathways. We will explore the hypothesis that this gross loss of gene regulatory control underpins the multifarious toxicities of dioxin poisoning.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Proteomics of arthritis: Exploring mechanisms of cartilage degradation and biomarker identification
-
批准号:nhmrc : 491237
-
项目类别:NHMRC Project Grants
-
资助金额:$39.48万
-
财政年份:2008
-
负责人:Prof Jeffrey Gorman
-
依托单位:
Tandem Matrix-Assisted Laser Desorption/Ionisation Time-Of-Flight Mass Spectrometer and Robots for High Throughput Proteomics Analysis
-
批准号:LE0454052
-
项目类别:Linkage Infrastructure, Equipment and Facilities
-
资助金额:$48.92万
-
财政年份:2004
-
负责人:Prof Jeffrey Gorman
-
依托单位:
Identification and function of posttranslational modifications in the Dioxin Receptor/Arnt transcription factor
-
批准号:nhmrc : 299053
-
项目类别:NHMRC Project Grants
-
资助金额:$29.91万
-
财政年份:2004
-
负责人:Prof Jeffrey Gorman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
去泛素化酶USP21在纺锤体定向调控中的作用及分子机制
-
批准号:32000481
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:戚菲菲
-
依托单位:
骨肉瘤中融合蛋白RAB22A-NeoF1的降解调控机制及临床意义
-
批准号:32070765
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:廖丹
-
依托单位:
靶向干预PKCα- MAP4K4-SASH1磷酸化信号通路阻止三阴型乳腺癌侵袭转移的机制研究
-
批准号:32060165
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2020
-
负责人:周定安
-
依托单位:
端锚聚合酶TNKS通过泛素连接酶RNF146调控抗病毒天然免疫的机制研究
-
批准号:32070773
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:雷曹琦
-
依托单位:
E3泛素连接酶UBR5调控O-GlcNAc糖基化在胰腺癌吉西他滨耐药中的作用及机制研究
-
批准号:32060166
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:杜云艳
-
依托单位:
USP33调控Viperin蛋白泛素化及IFN抗病毒活性的机制研究
-
批准号:32000540
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:袁玉康
-
依托单位:
DNA碱基损伤修复酶OGG1调控NF-κB磷酸化修饰的作用及机制研究
-
批准号:31900557
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:王若曦
-
依托单位:
TLS聚合酶Polη乙酰化修饰的动态调控和功能研究
-
批准号:31970740
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:郭彩霞
-
依托单位:
细胞膜受体调控mTORC2活化的新机制研究
-
批准号:31970717
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:罗永挺
-
依托单位:
MG53蛋白的翻译后修饰调节及其应用研究
-
批准号:31970722
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:吕凤祥
-
依托单位: